We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Patrick Industries
PATK
$2.95B
| $5.68M | 0.01% |
106,443
-3,770
| -3% | -$178K |
|
1302
Elanco Animal Health
ELAN
$11.1B
| $5.67M | 0.01% |
563,616
+82,840
| +17% | +$769K |
|
1303
Knowles
KN
$3.34B
| $5.67M | 0.01% |
313,683
+15,490
| +5% | +$261K |
|
1304
Duolingo
DUOL
$6.12B
| $5.64M | 0.01% |
39,432
+7,363
| +23% | +$1.06M |
|
|
CNR
1305
Core Natural Resources Inc
CNR
$4.45B
| $5.63M | 0.01% |
83,000
+3,324
| +4% | +$203K |
|
1306
Dr. Reddy's Laboratories
RDY
$10.2B
| $5.61M | 0.01% |
+444,730
| New | +$5.19M |
|
1307
Pacira BioSciences
PCRX
$997M
| $5.61M | 0.01% |
140,049
+2,930
| +2% | +$121K |
|
1308
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $5.61M | 0.01% |
253,919
-4,076
| -2% | -$88.6K |
|
1309
Bank of Hawaii
BOH
$3.13B
| $5.57M | 0.01% |
135,110
+8,297
| +7% | +$367K |
|
|
GAP
1310
The Gap Inc
GAP
$7.37B
| $5.56M | 0.01% |
622,998
+5,096
| +0.8% | +$45.5K |
|
1311
Cinemark Holdings
CNK
$4.32B
| $5.56M | 0.01% |
337,069
-10,282
| -3% | -$171K |
|
1312
Gentherm
THRM
$1.27B
| $5.55M | 0.01% |
98,220
-338
| -0.3% | -$19.5K |
|
|
VRTV
1313
DELISTED
VERITIV CORPORATION
VRTV
| $5.54M | 0.01% |
44,123
+1,971
| +5% | +$231K |
|
1314
MGP Ingredients
MGPI
$375M
| $5.53M | 0.01% |
52,043
+2,603
| +5% | +$260K |
|
1315
NovoCure
NVCR
$1.91B
| $5.52M | 0.01% |
133,117
+15,353
| +13% | +$953K |
|
1316
Pinduoduo
PDD
$131B
| $5.52M | 0.01% |
+79,818
| New | +$5.48M |
|
1317
CorVel
CRVL
$3.19B
| $5.51M | 0.01% |
85,446
-1,290
| -1% | -$86.3K |
|
1318
WaFd
WAFD
$2.75B
| $5.5M | 0.01% |
207,324
-1,940
| -0.9% | -$53.7K |
|
|
ALTR
1319
DELISTED
Altair Engineering Inc
ALTR
| $5.49M | 0.01% |
72,387
+1,800
| +3% | +$129K |
|
1320
Cactus
WHD
$5.44B
| $5.48M | 0.01% |
129,564
+9,697
| +8% | +$378K |
|
1321
Standex International
SXI
$4.12B
| $5.48M | 0.01% |
38,743
-966
| -2% | -$128K |
|
1322
Certara
CERT
$1.25B
| $5.47M | 0.01% |
300,412
-63,425
| -17% | -$1.34M |
|
|
ODP
1323
DELISTED
ODP
ODP
| $5.47M | 0.01% |
116,742
-21,370
| -15% | -$917K |
|
|
TTM
1324
DELISTED
Tata Motors Limited
TTM
| $5.45M | 0.01% |
+216,782
| New | +$5.45M |
|
1325
Herc Holdings
HRI
$5.61B
| $5.44M | 0.01% |
39,766
+3,303
| +9% | +$366K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.